FindTrial
Sign In

ASSESMENT OF ALABU MODAK FOR TREATMENT OF RAKTA PRADAR (MENORRHAGIA): EVIDENCE FROM RANDOMIZED CONTROLLED TRIAL

CLINICAL EFFICACY OF ALABU MODAK IN RAKTA PRADARA W S R TO MENORRHAGIA A RANDOMIZED CONTROL TRIAL - not applicable

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108944
Enrollment
60
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Dr Shrutisudhakar Bagul
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 13-55 yrs Patients with complaints of heavy menstrual bleeding interfering with their daily activities

Exclusion criteria

Exclusion criteria: Post menopausal bleeding Pregnancy Thyroid dysfunction Congenital and anatomical defects Other diseases known to interfere with menstrual bleeding such as leiomyomas greater than 3 cm polyp ovarian tumor CA of genital organs Patients suffering from chronic systemic diseases Patient having severe anemia Patient having history of previous thromboembolic disorders

Design outcomes

Primary

MeasureTime frame
It will decrease the excessive bleeding in the mensesTimepoint: 3 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Manjusri Sahoo

Gopabandhu Ayurveda Mahavidyalaya Puri

dr.manjusrisahoo@gmail.com6370491066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026